Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial

Overview of attention for article published in Multiple Sclerosis Journal, December 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source

twitter: 4 X users

Readers on

mendeley: 67 Mendeley

Summary Blogs Policy documents X

So far, Altmetric has seen 2 posts from 2 blogs.

Minder ziekteverzuim na jaar Tysabri

MSweb RSS Feed, 14 Feb 2014

Zweedse onderzoekers hebben aangetoond dat mensen zich minder vaak ziek hoefden te melden op het werk na een jaar Tysabri…

Tysabri stops you having a Sickie

Multiple Sclerosis Research, 02 Jan 2014

Wickström A, Dahle C, Vrethem M, Svenningsson A.Reduced sick leave in multiple sclerosis after one year of natalizumab treatment.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.